Page last updated: 2024-08-21

isoxazoles and paroxetine

isoxazoles has been researched along with paroxetine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saria, A; Schatz, DS1
Ancione, M; Avenoso, A; Facciolà, G; Madia, A; Scordo, MG; Spina, E1
Furukori, H; Kaneko, S; Nakagami, T; Saito, M; Yasui-Furukori, N1
Berwaerts, J; Chang, I; Cleton, A; Eerdekens, M; Herben, V; van de Vliet, I; van Hoek, P1
Canovi, M; Dallanoce, C; De Amici, M; De Micheli, C; Gobbi, M; Matera, C; Mennini, T1
Hochfeld, M; Meng, X; Potkin, SG; Preskorn, S1
Preskorn, SH1

Trials

3 trial(s) available for isoxazoles and paroxetine

ArticleYear
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients.
    Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Schizophrenia

2005
The effects of paroxetine on the pharmacokinetics of paliperidone extended-release tablets.
    Pharmacopsychiatry, 2009, Volume: 42, Issue:4

    Topics: Adolescent; Adult; Antipsychotic Agents; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Young Adult

2009
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:1

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dibenzothiazepines; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Electrocardiography; Enzyme Inhibitors; Female; Genotype; Heart Rate; Humans; Isoxazoles; Ketoconazole; Linear Models; Long QT Syndrome; Male; Middle Aged; Paroxetine; Pharmacogenetics; Phenotype; Piperazines; Piperidines; Quetiapine Fumarate; Thiazoles; United States; Young Adult

2013

Other Studies

4 other study(ies) available for isoxazoles and paroxetine

ArticleYear
Simultaneous determination of paroxetine, risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with coulometric detection.
    Pharmacology, 2000, Volume: 60, Issue:1

    Topics: Chromatography, High Pressure Liquid; Colorimetry; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Spectrophotometry, Ultraviolet

2000
Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine.
    Therapeutic drug monitoring, 2001, Volume: 23, Issue:3

    Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Selective Serotonin Reuptake Inhibitors

2001
A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake.
    Bioorganic & medicinal chemistry, 2012, Nov-01, Volume: 20, Issue:21

    Topics: Animals; Binding Sites; Cerebral Cortex; Citalopram; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Isoxazoles; Molecular Structure; Paroxetine; Rats; Serotonin; Serotonin Plasma Membrane Transport Proteins; Spiro Compounds; Structure-Activity Relationship; Synaptosomes

2012
Complexities of personalized medicine: how genes, drug-drug interactions, dosing schedules, and other factors can combine to produce clinically meaningful differences in a drug's effect.
    Journal of psychiatric practice, 2013, Volume: 19, Issue:5

    Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Depressive Disorder, Major; Dizziness; Drug Interactions; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Isoxazoles; Male; Paroxetine; Pharmacogenetics; Piperidines; Precision Medicine

2013